RANKINGS

POPULAR STOCKS

ICON Public Limited Company

NasdaqGS:ICLR

Location

Ireland

Market Cap

USD 11.60 B

Share Price

USD 145.91

Avg Daily Volume

1,488,263

Change (1 day)

-1.77%

Change (1 year)

-53.75%

Change (YTD)

-30.42%

ICON Public Limited Company Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 1.06 B

ICON Public Limited Company Free Cash Flow is USD 1.06 B for the Trailing 12 Months (TTM) ending March 31, 2025, a -9.11% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
  • ICON Public Limited Company Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 1.16 B, a 220.40% change year over year.
  • ICON Public Limited Company Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 362.63 M, a -56.80% change year over year.
  • ICON Public Limited Company Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 839.46 M, a 71.76% change year over year.
  • ICON Public Limited Company Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 488.75 M, a 20.46% change year over year.
Key data
Date Free Cash Flow Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities
Market news
NasdaqGS: ICLR

ICON Public Limited Company

CEO Dr. Steven A. Cutler MBA, Ph.D.
IPO Date May 15, 1998
Location Ireland
Headquarters South County Business Park
Employees 41,250
Sector 🏥 Health Care
Industries
Clinical Trials
🧬 Biotechnology
💻 Telehealth
Description

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.

Similar companies

BSX

Boston Scientific Corporation

USD 104.29

0.16%

SHL.DE

Siemens Healthineers AG

USD 54.76

0.58%

GEHC

GE HealthCare Technologies Inc.

USD 72.75

1.07%

NTRA

Natera, Inc.

USD 164.16

-4.49%

LH

Laboratory Corporation of America Holdings

USD 258.70

-1.46%

BAX

Baxter International Inc.

USD 30.61

0.07%

TORNTPHARM.NS

Torrent Pharmaceuticals Limited

USD 37.11

-1.05%

RGC

Regencell Bioscience Holdings Limited

USD 21.73

-5.32%

ASND

Ascendis Pharma A/S

USD 173.00

-3.41%

EXAS

Exact Sciences Corporation

USD 51.92

1.47%

CTEC.L

ConvaTec Group Plc

USD 3.96

0.77%

300832.SZ

Shenzhen New Industries Biomedical Engineering Co., Ltd.

USD 8.00

0.06%

GH

Guardant Health, Inc.

USD 49.90

-0.18%

DIA.MI

DiaSorin S.p.A.

USD 109.19

-0.66%

3347.HK

Hangzhou Tigermed Consulting Co., Ltd.

USD 4.54

-5.44%

LNTH

Lantheus Holdings, Inc.

USD 80.55

-0.49%

688617.SS

APT Medical Inc.

USD 41.26

1.54%

TMDX

TransMedics Group, Inc.

USD 128.58

-3.06%

ADMA

ADMA Biologics, Inc.

USD 17.60

-1.40%

LAURUSLABS.NS

Laurus Labs Limited

USD 7.78

-0.11%

IPCALAB.NS

Ipca Laboratories Limited

USD 15.81

0.19%

INSP

Inspire Medical Systems, Inc.

USD 132.00

-0.42%

600566.SS

Hubei Jumpcan Pharmaceutical Co., Ltd.

USD 3.93

1.22%

002603.SZ

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

USD 1.97

-0.21%

PFIZER.NS

Pfizer Limited

USD 65.60

1.28%

300676.SZ

BGI Genomics Co., Ltd.

USD 6.92

-0.27%

ERIS.NS

Eris Lifesciences Limited

USD 18.85

-0.41%

LIVN

LivaNova PLC

USD 45.87

-0.35%

300529.SZ

Jafron Biomedical Co.,Ltd.

USD 2.99

0.64%

VIMIAN.ST

Vimian Group AB (publ)

USD 4.23

-3.41%

VCYT

Veracyte, Inc.

USD 26.45

-1.60%

BAVA.CO

Bavarian Nordic A/S

USD 26.28

-0.67%

0853.HK

MicroPort Scientific Corporation

USD 1.09

1.19%

VITR.ST

Vitrolife AB (publ)

USD 14.21

-1.42%

QDEL

QuidelOrtho Corporation

USD 28.11

-1.95%

NVCR

NovoCure Limited

USD 17.32

1.91%

HRMY

Harmony Biosciences Holdings, Inc.

USD 31.57

-1.53%

603882.SS

Guangzhou Kingmed Diagnostics Group Co., Ltd.

USD 3.99

0.81%

CERT

Certara, Inc.

USD 10.86

1.59%

ARQT

Arcutis Biotherapeutics, Inc.

USD 14.47

0.98%

002287.SZ

Tibet Cheezheng Tibetan Medicine Co., Ltd.

USD 3.14

-0.23%

688289.SS

Sansure Biotech Inc.

USD 2.86

-0.42%

INDGN.NS

Indegene Limited

USD 6.78

0.44%

ADPT

Adaptive Biotechnologies Corporation

USD 11.98

12.49%

603567.SS

Heilongjiang ZBD Pharmaceutical Co., Ltd.

USD 1.68

0.72%

002020.SZ

Zhejiang Jingxin Pharmaceutical Co., Ltd.

USD 1.80

-0.78%

300026.SZ

Tianjin Chase Sun Pharmaceutical Co.,Ltd

USD 0.52

-0.59%

605507.SS

Guobang Pharma Ltd.

USD 2.73

-1.40%

688016.SS

Shanghai MicroPort Endovascular MedTech Co., Ltd.

USD 12.29

-0.52%

BHVN

Biohaven Ltd.

USD 14.33

-2.98%

StockViz Staff

June 27, 2025

Any question? Send us an email